91260-08-1 Usage
1,3-thiazolidine framework
The compound has a 1,3-thiazolidine structure, which is a five-membered ring containing two sulfur atoms and one oxygen atom.
Furan ring
The compound contains a furan ring, which is a five-membered ring with one oxygen atom.
Thiadiazole ring
The compound also contains a thiadiazole ring, which is a five-membered ring with two sulfur atoms and one oxygen atom.
Heterocyclic compound
The compound is a heterocyclic compound, meaning it contains at least one ring with atoms other than carbon.
Potential pharmaceutical applications
The compound has potential pharmaceutical applications due to its unique structure and potential biological activities.
Antidiabetic properties
The compound has been studied for its potential antidiabetic properties, which could make it useful in the treatment of diabetes.
Anti-inflammatory properties
The compound has been studied for its potential anti-inflammatory properties, which could make it useful in the treatment of inflammation-related conditions.
Antioxidant properties
The compound has been studied for its potential antioxidant properties, which could make it useful in the prevention of oxidative stress-related conditions.
Interesting target for further research
The distinct structure and potential biological activities of the compound make it an interesting target for further research and potential drug development.
Check Digit Verification of cas no
The CAS Registry Mumber 91260-08-1 includes 8 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 5 digits, 9,1,2,6 and 0 respectively; the second part has 2 digits, 0 and 8 respectively.
Calculate Digit Verification of CAS Registry Number 91260-08:
(7*9)+(6*1)+(5*2)+(4*6)+(3*0)+(2*0)+(1*8)=111
111 % 10 = 1
So 91260-08-1 is a valid CAS Registry Number.
91260-08-1Relevant articles and documents
Compounds with presumable antitumor activity. II. 2-Substituted 3-(2-thiazolyl) and 3-[2-(1,3,4,-thiadizolyl)]-4-thiazolidinones
Grasso,Chimirri,Monforte,Fenech
, p. 505 - 513 (2007/10/02)
2-Substituted 3-(2-thiazolyl) and 3-[2-(1,3,4-thiadiazolyl)]-4-thiazolidinones were prepared and tested for their activity against the leukemic P 388 tumor system in mice. The thiadiazolyl derivatives are generally more active than the thiazolyl ones and some of them showed significant activity.
